Unlock siloed study data with cross-study search & meta-analysis

Join us for our webinar on Cross-Study Search & Meta-Analysis for Pharma R&D on March 3rd at 11am EST

Discover how to detect toxicity indicators earlier in the drug safety evaluation process by searching for hidden patterns and correlations across studies in a variety of formats and from multiple sources, including CROs and other partners. This webinar will discuss how cross-study search, navigation, and meta-analysis through Safety Data Integration & Search (SDIS™) can unlock legacy and live data, unstructured content and meta - data from in vivo, in vitro and other safety screening studies in order to reduce costly late-stage attrition.

We will feature case-study examples, lessons learned, and how early safety assessments can result in significant savings and higher-profit pipelines. This free session is targeted towards toxicologists, other drug safety evaluation scientists, and informatics personnel. It will feature 45 minutes of discussion followed by a Q&A session.

Speakers

Dr. Jon Kimball, President, Potter-Hawkins Group, LLC Dr.
Kimball has over 30 years of experience in the pharmaceutical non-clinical laboratory drug safety assessment and human clinical diagnostic healthcare industries, and is presently founder and president of the Potter-Hawkins Group LLC, a toxicologic clinical pathology and drug development consulting organization. Specializing in interdisciplinary integration, Dr. Kimball has experience in the application of broad scientific skills to Pharmaceutical Discovery and Development, to investigative discovery risk assessment, NCE optimization, and to technology development, acquisition, validation, and Quality Assurance and Regulatory processes. Dr. Kimball's consulting with diagnostic, biotech and pharmaceutical development companies has included the areas of technology applications development, regulatory compliance and validation requirements, and pharmaceutical preclinical Drug Discovery and Safety Assessment interpretative analyses and strategic program planning.

Shree Nath, Ph.D, Vice-President of Pharmaceuticals and HLS, PointCross
Dr. Nath leads PointCross's Pharmaceutical offerings, with an emphasis on search, business process orchestration, knowledge management and regulatory data exchange. He works closely with pharmaceutical companies to develop custom user-oriented solutions for decision support in knowledge-intensive, decision-centric and collaborative environments. He is an active member of the CDISC SEND committee and serves on the CDISC Advisory Board. He also manages PointCross's relationships with global partners, sponsors, CROs and regulatory agencies. Shree received a dual Ph.D. from Oregon State University in 1996. Prior to PointCross, he led environmental impact assessments for a consulting firm and was faculty at the University of Georgia in Decision Support and Artificial Intelligence.

Moderator: Philip Drew, Managing Director, PDS
Philip Drew is managing director of UK technology company PDS Computer Software Ltd. which is an ISO 9001 accredited supplier of IT design, development, validation, remediation, support, audit, security assessment, risk management and quality assurance services to the life sciences sector. Recent assignments have involved the extraction and preservation of safety data from legacy toxicology systems from which PDS has a built an international reputation. Mr. Drew has a unique combination of regulatory, business and technical expertise in the application of Information Technology within life sciences. He is currently providing safety data consulting services to Hoffmann-La Roche Inc.

Learn More

• See SDIS™ in action
• Join us for our session on "Early Safety Assessments Through Semantically Relevant Search & Data Exchange" at ToxExpo March 8th-10th
• Join us for our panel presentation with the FDA at DIA/FDA's Annual Meeting on March 22nd-23rd

Contact
For more information on SDIS™ and our other solutions for pharma, contact:
Dr. Shree Nath,
VP of Pharmaceuticals
E-mail:
or call us at +1 (650) 350-1900

Goto Top